1Mahoney BP,Raghunand N,Baggett B,et al. Tumor acidity,ion trapping and chemotherapeutics I . Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol, 2003,66 (7):1207-1218.
2Marx J. How cells endure low oxygen. Science, 2004,303 (5663):1454-1456.
3Horsman MR. Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys,1998,42(4) :701-704.
4Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol, 2003,67(1) :3-15.
5Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Hypoxia-inducible factor ( HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and neck cancer. Int J Radiat Oncol Biol Phys ,2002,53 (5): 1192-1202.
6Rudat V, Vanseiow B, Wollensack P, et al. Repeatability and prognostic impact of the pretreatment pO2 histography in patients with advanced head and neck cancer. Radiother Oncol,2000,57(1) :31-37.
7Stadler P, Becker A, Feldmann H J, et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys, 1999,44 (4) :749-754.
8Shannon AM, Bouchier Hayes DJ, Condron CM, et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev,2003,29 (4) :297-307.
9Vaupel P,Thews O, Hoeckel M. Treatment resistance of solid tumors:role of hypoxia and anemia. Med Oncol,2001,18 (4) :243-259.
10Brown JM. The hypoxic cell:a target for selective cancer therapyEighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res,1999,59(23 ) :5863-5870.
